Aehr Test Systems is trading at $84.15 (4.2% down) in pre-market, pulling back as investors lock in gains following a sharp two-day surge driven by a strong Q4 2026 earnings beat and robust fiscal 2027 growth guidance.
- The move reflects consolidation after the company reported record bookings and an effective backlog exceeding $100 million, supported by a strategic pivot toward AI-focused testing solutions.
- Shares are facing additional downward pressure from a broader sell-off across the semiconductor sector, despite the company's positive long-term momentum.